HSP90 triggers EMT in colorectal cancer cells through sustained activation of the NF-κB signaling pathway, and subsequent downregulation of the epithelial marker E-cadherin and upregulation of the mesenchymal marker Vimentin [16]. The gene discussed is HSP90AB1; the disease is colorectal cancer.